907 results found | searching for "pharma"
-
-
Nanofiltration Membrane Market Size, Share, Forecast 2022-2028 The global nanofiltration membrane market size was valued at USD 724.6 billion in 2021 and is poised to grow at a significant CAGR of 6.3% during the forecast period 2022-28. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC “Nanofiltration Membrane Market: By Type (Hybrid, Inorganic and Polymeric), By Application (Chemical & Petrochemicals, Food & Beverages, Pharmaceutical & Biomedical, Water & Wastewater Treatment and Others) and Geography-Global/Region/Country Forecast to 2028.” [more]
-
-
Dysphagia Supplements Market Size | Share | Opportunities 2022 The global dysphagia supplements market size was valued at USD 1504.6 billion in 2021 and is poised to grow at a significant CAGR of 5.6% during the forecast period 2022-28. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC “Dysphagia Supplements Market: By Product Type (Powder thickeners, Instant food, Ready to drink thickened beverages, Oral nutritional supplements), by Distribution Channel (Hospitals, Retail Pharmacies, Others) - Global/Region/Country Forecast to 2028.” [more]
-
-
Block Chain Technology in Healthcare Market Size, Share, Forecast 2022-2028 The global block chain technology in healthcare market size was valued at USD 550.1 billion in 2021 and is poised to grow at a significant CAGR of 19.5% during the forecast period 2022-28. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on “Block Chain Technology in Healthcare Market: By Application (Clinical Data Exchange & Interoperability, Supply Chain Management, and Claims Settlement & Billing), By End User (Healthcare Payers, Pharmaceutical Companies, and Healthcare Providers), and Geography-Global/Region/Country Forecast to 2028.” [more]
-
-
The Artificial Intelligence in Oncology market is anticipated to grow at a CAGR of 54% claims Roots Analysis With an aim to counter the increasing number of cancer cases, researchers across the globe have developed AI-based solutions for the early diagnosis of a wide range of cancer indications. Currently, various AI algorithms are being used in cancer imaging. Roots Analysis is pleased to announce the publication of its recent study, titled, “Artificial Intelligence in Oncology Market, 2022-2035.” It is worth highlighting that 26% of the players engaged in this domain are using both machine learning and deep learning technologies. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/ai-in-oncology-market/request-sample.html The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this technology over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: A detailed overview of the overall market landscape of players engaged in the development of artificial intelligence in oncology software solutions. Elaborate profiles of prominent players that specialize in offering artificial intelligence in oncology- based software solutions. A competitiveness analysis of artificial intelligence in oncology- based software providers, based on supplier strength, portfolio diversity and portfolio strength. An in-depth analysis of patents related to artificial intelligence in oncology- based software solutions, filed / granted till date. An analysis of the partnerships that have been established in this domain, in the recent past. A detailed analysis of various investments made by players engaged in this domain, during the period 2017-2021. A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) Type of Cancer Solid Malignancies Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Brain Tumor Others Type of End-User Hospitals Pharma Companies Research Institutes Others Key Geographical Regions North America Europe Asia Pacific Rest of the World Key companies covered in the report Ibex Medical Analytics Niramai Optellum Tempus Labs Paige Kheiron Medical Technologies For additional details, please visit https://www.rootsanalysis.com/reports/ai-in-oncology-market.html You may also be interested in the following titles: 1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035 2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com [more]
-
-
The global karaya gum market is expected to witness moderate growth during the forecast period. Growth in revenue of karaya gum is primarily driven by an increase in consumer demand for food with natural ingredients coupled with the continued use of karaya gum in the pharmaceutical industry. According to a recently published report by Persistence Market Research titled “Karaya Gum Market: Global Industry Analysis (2012–2016) & Forecast (2017–2025),” the global market for karaya gum is expected to expand at a CAGR of 3.4% in terms of value during the forecast period 2017-2025. It has been observed that the global production of karaya gum has been declining since the past decade. This is mainly attributed to the cutting down of forests across major gum producing countries like India. The global karaya gum market is expected to reach a of US$ 90.1 Mn by 2025, owing to the increasing use of karaya gum in drug formulations and in the food industry. Request For Report Sample – https://tinyurl.com/9scw2k9a [more]
-
-
enrollment period. Therefore, we propose that you enroll on time if you need to keep away from overdue enrollment penalty as far as health insurance coverage is involved. #5: Your Original Medicare might not cover your prescribed drugs With authentic Medicare, you may experience Limited insurance with regards to pharmaceuticals. On the opposite hand, in case you are seeking out complete coverage, you can cross for a Part D prescription drug plan. It is even higher that you bear in mind a private insurance business enterprise to use for this plan. Long story brief, we recommend that you keep away from those 5 errors as far as Medicare supplement coverage is involved. Hopefully, in case you observe the tips defined in this newsletter, you will be able to avoid some common errors. Article Source http://topgamehaynhat.net/members/qdtmcoax.118343/#about https://creator.wonderhowto.com/qdtmcoaxladies/ https://medium.com/@berzucikne/right-mildew-can-hug-the-inner-ear-enough-to-lead-them-to-barely-important-65be878c991 http://playit4ward-sanantonio.ning.com/profile/qdtmcoax https://www.hoomet.com/forums/topic/38540/-/view/post_id/257997 http://grainsight.com/index.php/forum/welcome-mat/906796-qualified-audiologist https://qdtmcoax.contently.com/?public_only=true http://gendou.com/forum/thread.php?thr=43594 https://warengo.com/stories/270754-more-than-500-individuals-who-suffered-from-hearing https://www.hellopeter.com/profile/669fdc30-b76f-11ed-a447-09df90dca7fe [more]
-
-
https://precisionbusinessinsights.com/market-reports/global-oral-care-products-market/ Oral Care Products Market by Product Type (Toothpastes, Gels, Pastes, Powders, Toothbrushes, Electrical, Manual, Battery powered, Mouthwashes, Medicated mouthwashes, Non-medicated mouthwashes, Gargles and Dental prosthesis and cleaning products), By Application (Dental cavities, Tooth decay, Tooth loss, Periodontal disease and Oral ulcers), By Formulation (Powders, Liquids and Semi-solids), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies, Drug Stores and Retail Stores) and Geography -
-
Stannic Chloride Market Trends, Forecast 2022-28 The global stannic chloride market size was valued at USD x billion in 2021 and is poised to grow at a significant CAGR of 3.9% during the forecast period 2022-28. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on “Stannic Chloride Market: By Product (Liquid and Solid), By End User (Agriculture, Pharmaceuticals, Polymers, Electrical & Electronics, Chemical and Others) and Geography- Global/Region/Country Forecast to 2028.” [more]
-
-
PRESENTLY, AROUND 80 4D BIOPRINTERS AND SMART BIOMATERIALS ARE BEING DEVELOPED BY VARIOUS INDUSTRY AND NON-INDUSTRY PLAYERS, EQUIPPED WITH THE VITAL CAPABILITIES THAT CAN BE USED ACROSS A WIDE RANGE OF APPLICATION AREAS During our research, we were able to identify close to 80 bioprinters and smart biomaterials that are in different stages of development for the treatment of various diseases. It is worth highlighting that 50% players developing 4D bioprinters have established their presence in the domain after 2012. This indicates that the market is driven by the efforts of new players, majority of which have around 10 years of experience; prominent examples include (in reverse chronological order of their year of establishment) BRIGHTER (2020), Readily3D (2020), TissueLabs (2019) and Nuclera (2013). It is worth mentioning that pre-1985, seven companies have been established; examples include (in reverse chronological order of their year of establishment) 3D Systems (1983), University of Wollongong (1975) and Rutgers University (1766). Presently, the 4D bioprinting technology is being explored for use across various application areas in the biomedical industry, leading to an increase in opportunities within this domain To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/4d-bioprinting-market/request-sample.html Further, 55% players developing smart biomaterials have entered this field before 1970. This indicates that the market is driven by the efforts of well-established players, majority of which have more than 45 years of experience; prominent examples include (in reverse chronological order of their year of establishment) University of Birmingham (1900), RWTH Aachen University (1870), University of Georgis (1785) and Harvard University (1636). It is worth mentioning that post 2014, six new companies have been established; examples include (in reverse chronological order of their year of establishment) Instituto de Nanociencia y Materiales de Aragón (2020), 4D Biomaterials (2018), NanoBio Lab (2018), 1ST GRAPHENE (2016), NanoRegMed (2016) and Grolltex (2015) Moreover, companies developing 4D bioprinters and smart biomaterials have been segregated under three categories, namely small (less than 50 employees), mid-sized (51-500 employees) and large companies (more than 500 employees). It is important to mention that, for the purpose of this analysis, information has been sourced primarily from company websites and other reliable sources, such as LinkedIn. As can be observed in the figure, polymer (58%) emerged as the most preferred type of biomaterial. This is followed by natural type of biomaterial (49%). It is worth mentioning that biomaterials offer variety of applications such as making implants / protheses and medical devices, as they have the unique ability to replace or restore the lost or impaired bodily functions. Further, 58% 4D bioprinters have already been commercialized while 42% 4D bioprinters are under development phase. Examples of some commercialized 4D bioprinters include (in alphabetical order, no selection criteria) NGB-R, Organ.Aut, Origin One and Tomolite. Moreover, laser-based technology is the most preferred (42%) type of technology used in 4D bioprinters. This can be attributed to the fact that lased-based technology utilizes a nozzle free approach. The presence of nozzle can harm the cell viability sometimes, while its absence significantly improves the same. Further, this nozzle-free approach also allows to adjust the viscosity of bioink as per the need. As can be observed in the figure, 23% polymer-based smart biomaterials and 8% smart biomaterials made of natural components have already been commercialized. While 44% polymer-based smart biomaterials and 20% smart biomaterials made of natural components are under development. Notable examples of commercialized polymer-based smart biomaterials include (in alphabetical order, no selection criteria) 4Degra resin ink, SLA Resins and Porcine collagen-based hydrogel. Further, maximum number of smart biomaterials (23%) are available in sheet form. This is followed by 14% smart biomaterials available in liquid form. Further, there are 11% smart biomaterials available in gel and versatile forms, each. Moreover, most of the smart biomaterials (28) marketed / being developed can be used in the field of tissue engineering and regenerative medicine. It is worth mentioning that 4D printed pictures of tissues are used to manufacture patient-specific tissue structures using computer-aided design (CAD), along with other digital imaging methods such as magnetic resonance imaging (MRI) and X-ray computed tomography (CT). This is followed by six smart biomaterials that can be applied in the domain of orthopedics. For additional details, please visit https://www.rootsanalysis.com/reports/4d-bioprinting-market.html You may also be interested in the following titles: 1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035 2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com [more]
-
-
https://precisionbusinessinsights.com/market-reports/global-next-generation-sequencing-market/ Next-Generation Sequencing Market: By Product And Service Type (Pre-sequencing products and services market,( DNA fragmentation, size selection, A-tailing, and end repair, Library preparation and target enrichment, Quality control), Sequencing services market (Targeted sequencing/gene panels, RNA-Seq, De Novo sequencing, Exome sequencing, Chip-Seq, Whole-genome sequencing, Methyl-Seq, others ), Next-generationn Sequencing, Data Analysis, storage, and management (Bioinformatics) market (NGS data analysis software & workbenches, NGS data analysis services, NGS storage management and cloud computing solutions)), By Technology (Ion semiconductor sequencing, Sequencing by the synthesis (SBS), Nanopore sequencing, Single-molecule real-time (SMRT) sequencing), By Application (Drug discovery, Diagnostics, Agriculture and animal research, Biomarker discovery, Precision medicine, Other applications),BY End User (Biotechnology and Pharmaceutical Companies, Research Centres, Hospitals & Clinics, Others), and Geography
Copyright 2019 © P-tweets Refunds